Refresh

Pharmaids Pharmaceuticals Ltd. - Research Center

524572 PHARMAID Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

- 3.94 8.55 - 0.48
Expenses

Material consumed

0.89 3.57 8.16 - 0.36

Manufacturing expenses

- - - - -

Personnel expenses

1.13 0.04 0.04 0.02 0.03

Selling expenses

0.01 - 0.01 0.01 0.01

Adminstrative expenses

7.86 0.18 0.24 0.30 0.24

Expenses capitalised

- - - - -

Cost of sales

9.89 3.80 8.44 0.34 0.63

Operating profit

-9.89 0.14 0.11 -0.34 -0.15

Other recurring income

- 0.02 0.03 - 0.01

Adjusted PBDIT

- 0.15 0.13 - -0.15

Financial expenses

- - - - -

Depreciation

0.02 0.01 0.04 0.04 -

Other write offs

- - - - -

Adjusted PBT

-9.91 0.14 0.09 -0.38 -0.15

Tax charges

-2.35 - - -0.41 0.04

Adjusted PAT

-7.56 0.15 0.09 0.03 -0.18

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

-7.56 0.15 0.09 0.03 -0.18

Earnigs before appropriation

-9.89 -2.33 -2.48 -2.57 -2.61

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-9.89 -2.33 -2.48 -2.57 -2.61
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com